L&K Biomed Ltd. (KOSDAQ:156100)
South Korea
· Delayed Price · Currency is KRW 6,190.00
-120.00 (-1.90%)
At close: Mar 31, 2025, 3:30 PM KST
L&K Biomed Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 9,743 | -1,867 | -13,625 | -9,669 | -10,715 | Upgrade
|
| Depreciation & Amortization | 2,572 | 2,313 | 2,302 | 1,725 | 3,089 | Upgrade
|
| Loss (Gain) From Sale of Assets | -254.5 | -16.24 | 65.73 | -220.44 | 433.82 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 16.8 | 243.71 | 623.87 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -75.14 | -49.41 | - | -1,684 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 300 | 1,172 | 1,199 | 556.16 | 420.88 | Upgrade
|
| Stock-Based Compensation | 55.16 | 623.69 | 2,351 | 1,908 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 766.88 | -413.62 | 521.54 | 374.33 | 84.12 | Upgrade
|
| Other Operating Activities | -8,549 | 669.6 | 1,522 | -2,473 | 6,623 | Upgrade
|
| Change in Accounts Receivable | 659.7 | -2,093 | -522.25 | 50.06 | 6,999 | Upgrade
|
| Change in Inventory | -6,944 | -1,139 | -1,522 | 1,257 | -3,293 | Upgrade
|
| Change in Accounts Payable | 1,646 | -389.97 | 1,843 | -1,725 | -2,871 | Upgrade
|
| Change in Other Net Operating Assets | -7,350 | -196.13 | -1,259 | -1,323 | -1,548 | Upgrade
|
| Operating Cash Flow | -7,430 | -1,370 | -6,881 | -10,600 | -776.7 | Upgrade
|
| Capital Expenditures | -584.84 | -2,047 | 196.74 | 98.75 | -1,944 | Upgrade
|
| Sale of Property, Plant & Equipment | 383.96 | 237.83 | - | 1,389 | 40.7 | Upgrade
|
| Cash Acquisitions | - | - | -3.75 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -30.22 | -51.46 | -106.56 | 465.73 | -237.55 | Upgrade
|
| Investment in Securities | -8,880 | -4,243 | -2,560 | 3,229 | 858.57 | Upgrade
|
| Other Investing Activities | 9.92 | -9.09 | -27.94 | -32.26 | 14.37 | Upgrade
|
| Investing Cash Flow | -9,001 | -6,413 | -2,502 | 5,301 | -1,297 | Upgrade
|
| Short-Term Debt Issued | 1,500 | 7,136 | 1,345 | 1,533 | 15,268 | Upgrade
|
| Long-Term Debt Issued | 20,102 | 1,700 | - | 21,700 | 5,574 | Upgrade
|
| Total Debt Issued | 21,602 | 8,836 | 1,345 | 23,233 | 20,843 | Upgrade
|
| Short-Term Debt Repaid | -1,590 | -7,148 | - | -7,206 | -16,684 | Upgrade
|
| Long-Term Debt Repaid | -2,443 | -21,393 | -711.84 | -4,144 | -5,319 | Upgrade
|
| Total Debt Repaid | -4,033 | -28,541 | -711.84 | -11,350 | -22,003 | Upgrade
|
| Net Debt Issued (Repaid) | 17,569 | -19,705 | 632.73 | 11,884 | -1,160 | Upgrade
|
| Issuance of Common Stock | - | 25,334 | 100 | 1,348 | 1,338 | Upgrade
|
| Other Financing Activities | - | - | -0 | 3,121 | - | Upgrade
|
| Financing Cash Flow | 17,569 | 5,629 | 732.72 | 16,353 | 178.21 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2,350 | -193.5 | -62.93 | 143.24 | 2,162 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | 3,941 | Upgrade
|
| Net Cash Flow | -1,212 | -2,348 | -8,713 | 11,197 | 4,207 | Upgrade
|
| Free Cash Flow | -8,015 | -3,417 | -6,684 | -10,501 | -2,721 | Upgrade
|
| Free Cash Flow Margin | -22.21% | -11.43% | -33.81% | -68.31% | -14.06% | Upgrade
|
| Free Cash Flow Per Share | -368.54 | -210.46 | -498.99 | -784.49 | -228.82 | Upgrade
|
| Cash Interest Paid | 1,090 | 840.52 | 635.93 | 552.66 | 825.41 | Upgrade
|
| Cash Income Tax Paid | 94.5 | 329.24 | -22.33 | 0.1 | -3.94 | Upgrade
|
| Levered Free Cash Flow | -4,469 | -9,869 | -252.54 | 619.25 | 6,776 | Upgrade
|
| Unlevered Free Cash Flow | -2,794 | -8,618 | 1,126 | 1,482 | 7,491 | Upgrade
|
| Change in Net Working Capital | 6,729 | 10,727 | -4,345 | -6,834 | -8,781 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.